Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
Australia
Canberra Hospital, Canberra, Australian Capital Territory Westmead Hospital, Westmead, New South Wales The Prince Charles Hospital, Brisbane, Queensland Monash Medical Centre, Clayton, Victoria New Zealand
New Zealand Clinical Research, Christchurch Age range
16 Years and older
Last updated February 2025